Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China.

作者: Tao Li , Bang-Wei Cao , Yue Dai , Hong Cui , Hong-Li Yang

DOI: 10.1111/J.1440-1746.2008.05324.X

关键词: Internal medicineGenetic predispositionTransforming growth factorStomach cancerGenotypeTransforming growth factor betaCarcinogenesisCancerOncologyHaplotypeMedicineEndocrinology

摘要: Background and Aim:  As an important cytokine that modulate the cell cycle, involvement of transforming growth factor beta-1 (TGF-β1) in carcinogenesis has been extensively studied for many years. Literatures have demonstrated TGF-β1 gene polymorphisms may alter risk various cancers, such as lung, prostate breast. To investigate whether can modify gastric cancer, we conduct this hospital-based, case-control study. Methods:  One hundred sixty-seven cases 193 gender, age-matched healthy controls were enrolled study. C-509T T + 869C identified by PCR-RFLP ARMS-PCR protocols, respectively. Results:  Significantly different distributions both genes between case control. Variant genotypes −509CT, −509TT, +869TC +869CC associated with increased cancer (P = 0.001, OR = 2.54; P = 0.016, OR = 2.09; P < 0.001, OR = 3.46; OR = 4.04, respectively). With haplotype analysis, wild type CT (−509C +869T) led to a lower frequency than control (P < 0.001), while TC was more frequent (P < 0.001). Multiple logistic regression analysis revealed individuals had likelihood developing (OR = 3.19, 95%CI = 1.72–5.90). Conclusions:  Our findings imply −509C > T +869T > C be critical genetic susceptibility Chinese population.

参考文章(32)
Carlos A. González, Núria Sala, Gabriel Capellá, Genetic susceptibility and gastric cancer risk International Journal of Cancer. ,vol. 100, pp. 249- 260 ,(2002) , 10.1002/IJC.10466
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117
L. FUCCIO, R. M. ZAGARI, M. E. MINARDI, F. BAZZOLI, Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Alimentary Pharmacology & Therapeutics. ,vol. 25, pp. 133- 141 ,(2006) , 10.1111/J.1365-2036.2006.03183.X
Kyoung-Mu Lee, Sue Kyung Park, Nobuyuki Hamajima, Kazuo Tajima, Keun-Young Yoo, Aesun Shin, Dong-Young Noh, Sei-Hyun Ahn, Ari Hirvonen, Daehee Kang, Genetic polymorphisms of TGF-β1 & TNF-β and breast cancer risk Breast Cancer Research and Treatment. ,vol. 90, pp. 149- 155 ,(2005) , 10.1007/S10549-004-3859-2
Lawrence A. Wolfraim, Thomas M. Walz, Zakiya James, Tania Fernandez, John J. Letterio, p21Cip1 and p27Kip1 Act in Synergy to Alter the Sensitivity of Naive T Cells to TGF-β-Mediated G1 Arrest through Modulation of IL-2 Responsiveness Journal of Immunology. ,vol. 173, pp. 3093- 3102 ,(2004) , 10.4049/JIMMUNOL.173.5.3093
Christian C Boesen, Sergei Radaev, Shawn A Motyka, Apisit Patamawenu, Peter D Sun, The 1.1 Å Crystal Structure of Human TGF-β Type II Receptor Ligand Binding Domain Structure. ,vol. 10, pp. 913- 919 ,(2002) , 10.1016/S0969-2126(02)00780-3
J. Ignasi Elizalde, Josep M. Piqu??, Risk assessment in relatives of gastric cancer patients: hyperproliferation, genetics, and Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology. ,vol. 18, pp. 877- 879 ,(2006) , 10.1097/00042737-200608000-00013
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74
Rik Derynck, Ying E. Zhang, Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature. ,vol. 425, pp. 577- 584 ,(2003) , 10.1038/NATURE02006